0001493152-22-007040.txt : 20220316
0001493152-22-007040.hdr.sgml : 20220316
20220316191709
ACCESSION NUMBER: 0001493152-22-007040
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220310
FILED AS OF DATE: 20220316
DATE AS OF CHANGE: 20220316
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Barr Jason Michael
CENTRAL INDEX KEY: 0001645550
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-21617
FILM NUMBER: 22746251
MAIL ADDRESS:
STREET 1: 902 BROADWAY, 15TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10010
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ProPhase Labs, Inc.
CENTRAL INDEX KEY: 0000868278
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 232577138
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 711 STEWART AVE, SUITE 200
STREET 2: GARDEN CITY
CITY: NEW YORK
STATE: NY
ZIP: 11530
BUSINESS PHONE: (215) 345-0919
MAIL ADDRESS:
STREET 1: 711 STEWART AVE, SUITE 200
STREET 2: GARDEN CITY
CITY: NEW YORK
STATE: NY
ZIP: 11530
FORMER COMPANY:
FORMER CONFORMED NAME: QUIGLEY CORP
DATE OF NAME CHANGE: 19930328
4
1
ownership.xml
X0306
4
2022-03-10
0
0000868278
ProPhase Labs, Inc.
PRPH
0001645550
Barr Jason Michael
711 STEWART AVENUE,
SUITE 200
GARDEN CITY,
NY
11530
1
0
0
0
Common Stock, par value $0.0005
2022-03-10
2022-03-15
4
P
0
750
6.48
A
30991
D
The transaction reported herein was a purchase of Issuer common stock pursuant to an automatic broker-administered dividend reinvestment program.
/s/ Jason Barr
2022-03-16